GEMC-511687795836683
Awarded to K ENTERPRISES
₹1.5 L
Products
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Adalimumab 40 MG Injection | na / ORIADALI 40MG/0.4ML | 30049099 | - | - | - |
Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹1.5 LQualified Make: na
Model: ORIADALI 40MG/0.4ML
Title: Adalimumab 40 MG Injection 16 VIVEK INDUSTRIAL ESTATE WALBHAT RD GOREGAON EAST MUMBAI MUMBAI MAHARASHTRA 400063 | MUMBAI SUBURBAN | MAHARASHTRA | 400063 | Make: na
Model: ORIADALI 40MG/0.4ML
Title: Adalimumab 40 MG Injection | L1 | Qualified MII |
Tender Value
₹1.5 L
EMD Value
Exempted
Closing Date
16 Sept 2025, 12:00 pmClosed
Adalimumab 40 MG Injection
8268192
GEM/2025/B/6610497
Two Packet Bid
Adalimumab 40 MG Injection
GeM Contract
1 days
400707, Administration Building, Jawaharlal Nehru Port Authority, Sheva, Navi Mumbai Quanti ty Delivery to start after __________ Delivery to be completed by
Total value wise evaluation
PRODUCT_CUSTOM
Awarded to K ENTERPRISES
₹1.5 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Adalimumab 40 MG Injection | na / ORIADALI 40MG/0.4ML | 30049099 | - | - | - |
1 document required · 1 mandatory
Exempted
3 Oct 2025
26 Aug 2025
16 Sept 2025
Adalimumab 40 MG Injection | Brand:na | Model:ORIADALI 40MG/0.4ML | HSN:30049099
contract_GEMC-511687795836683.pdf
GEM_CONTRACT • 0.06 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8268192.pdf
GEM_BID
pr_revised_2025-08-25-15-59-18_2960114e22ee33cec2604e3dec28c977.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .